Monika Marona

Krakow, MA, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Thalamic and cerebral white matter volumes allow for identification of cognitively impaired patients with early relapsing-remitting multiple sclerosis.

Thalamic and cerebral white matter volumes allow for identification of cognitively impaired patients with early relapsing-remitting multiple sclerosis.

Journal: Neurologia i neurochirurgia polska

Published: August 12, 2025

Perspective of Disease and Treatment in Patients with Multiple Sclerosis: A Polish Multi-center Study.

Perspective of Disease and Treatment in Patients with Multiple Sclerosis: A Polish Multi-center Study.

Journal: Neurology and therapy

Published: July 11, 2025

Cladribine tablets as therapy for advanced relapsing-remitting multiple sclerosis: a 4-year follow-up real-world, multi-center, retrospective, cohort study.

Cladribine tablets as therapy for advanced relapsing-remitting multiple sclerosis: a 4-year follow-up real-world, multi-center, retrospective, cohort study.

Journal: Frontiers in neurology

Published: May 10, 2025

Baló's concentric sclerosis as a rare stroke mimic.

Baló's concentric sclerosis as a rare stroke mimic.

Journal: Neurologia i neurochirurgia polska

Published: April 09, 2025

Impact of interferon-β and dimethyl fumarate on nonlinear dynamical characteristics of electroencephalogram signatures in patients with multiple sclerosis.

Impact of interferon-β and dimethyl fumarate on nonlinear dynamical characteristics of electroencephalogram signatures in patients with multiple sclerosis.

Journal: Frontiers in neuroinformatics

Published: October 29, 2024

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.

Journal: Vaccines

Published: April 11, 2022

Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland.

Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland.

Journal: Frontiers in neurology

Published: April 05, 2022

Brain Under Fatigue - Can Perceived Fatigability in Multiple Sclerosis Be Seen on the Level of Functional Brain Network Architecture?

Brain Under Fatigue - Can Perceived Fatigability in Multiple Sclerosis Be Seen on the Level of Functional Brain Network Architecture?

Journal: Frontiers in human neuroscience

Published: January 11, 2022

Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland.

Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland.

Journal: Journal of clinical medicine

Published: September 15, 2021

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients.

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients.

Journal: Journal of clinical medicine

Published: March 03, 2021

Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.

Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.

Journal: Neurologia i neurochirurgia polska

Published: February 24, 2021

Neurological symptoms in hospitalised patients with COVID-19 and their association with in-hospital mortality.

Neurological symptoms in hospitalised patients with COVID-19 and their association with in-hospital mortality.

Journal: Neurologia i neurochirurgia polska

Published: December 31, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026